The following stocks are the leading risers and fallers among London Main Market small-caps on Monday.
SMALL-CAP - WINNERS
Oxford BioMedica PLC, up 6.9% at 244.25 pence, 12-month.
“Marketresearch.biz reports that the Drug Addiction Treatment Market size is expected to be worth around USD 24.4 Bn by 2032 from USD 10.9 Bn in 2022, growing at a CAGR of 8.6% during the forecast period from 2023 to 2032.Overview of the Drug Addiction Treatment MarketThe Drug Addiction Treatment Market encompasses.
Piper Sandler started coverage on shares of Q32 Bio (NASDAQ:QTTB – Free Report) in a report issued on Tuesday, Marketbeat.com reports. The brokerage issued an overweight rating and a $45.00 price target on the stock. Q32 Bio Stock Down 2.7 % QTTB stock opened at $20.71 on Tuesday. The company has a market cap of […]
Biotech ripe for cascade of dealmaking - Here are the top companies to watch By Investing com investing.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investing.com Daily Mail and Mail on Sunday newspapers.
Graphite Bio (NASDAQ:GRPH – Get Free Report) and Lyra Therapeutics (NASDAQ:LYRA – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, dividends and profitability. Insider & Institutional Ownership 54.3% of Graphite […]